As of 2025-07-10, the Net Margin of Zhejiang Shengda Bio-Pharm Co Ltd (603079.SS) is 3.6%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 3.6% |
2023-12-31 | -7.4% |
2022-12-31 | 4.3% |
2021-12-31 | 9.6% |
2020-12-31 | 22.8% |
2019-12-31 | 9.1% |
2018-12-31 | 9% |
2017-12-31 | 14.3% |
2016-12-31 | 12.6% |
2015-12-31 | 16.2% |